Lexicon Pharmaceuticals (NASDAQ:LXRX) is scheduled to announce Q3 earnings results on Tuesday, November 12th, after market ...

After being diagnosed with Type 1 diabetes at 16 years old, Rylee Arnold never thought she would be able to become a ...

A new system that combines high-speed video and an artificial intelligence (AI)-powered algorithm may offer quick, no-contact screenings for high blood pressure and Type 1 or Type 2 diabetes without ...

A tool powered by artificial intelligence that uses high-speed video to detect changes in blood flow in skin on the face and hands may offer a new way to screen for high blood pressure and diabetes ...

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

Childhood maltreatment — especially physical abuse and neglect — was associated with increased risks for adulthood obesity and type 2 diabetes.

Excess sugar links to many health risks. Learn how to cut back and replenish energy levels, prevent chronic diseases, and improve overall health.

The American Diabetes Association estimates that the average cost of diabetes ... such as co-payments at the doctor’s office ...

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...

Austinites gathered at The Pitch for the Breakthrough Type 1 Diabetes Walk to raise awareness and funding for advocacy and research into Type 1 diabetes.

the majority of panel members voted against the approval of sotagliflozin (Zynquista™) for use as an adjunct to insulin therapy for glycemic control in adults with type 1 diabetes (T1D) and chronic ...

GLP-1 drugs help manage diabetes and promote weight loss by mimicking the GLP-1 hormone, which works to control insulin and ...